Federal water and drug regulators agree. However, many researchers say the lack of required testing amounts to a ‘don’t ask, don’t tell’ plan about whether drugmakers are contributing to water pollution. It generally does not pass the straight-face test to state pharmaceutical manufacturers aren’t emitting the substances they’re creating, stated Kyla Bennett, who spent a decade as an EPA enforcement officer before getting an ecologist and environmental attorney. Pilot research in the U.S. And are today confirming those doubts abroad. Last year, the AP reported that trace amounts of a wide range of pharmaceuticals – including antibiotics, anti-convulsants, mood sex and stabilizers hormones – have been found in American drinking water supplies.In summary, we have found that there is absolutely no advantage of treatment with a proton-pump inhibitor in individuals with poorly controlled asthma who have minimal or zero symptoms of gastroesophageal reflux. Ambulatory pH monitoring and scientific characteristics do not recognize a subgroup that’s likely to benefit from such treatment.. Accelrys announces Modeling and Simulation Suite for optimizing R&D value chain Accelrys, Inc. , a leading scientific enterprise R&D software and services company, announced the Accelrys Modeling and Simulation Suite today, a pillar of the brand new Accelrys Enterprise R&D Architecture.